Inhalation toxicology of octamethylcyclotetrasiloxane (D4) following a 3-month nose-only exposure in Fischer 344 rats. 2002

Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
Pfizer, Inc, La Jolla, California, USA.

Octamethylcyclotetrasiloxane (D4) is a low-molecular-weight cyclic siloxane used primarily in the synthesis of silicone polymers. The objective of the present study was to evaluate the subchronic toxicity of D4 following a 3-month nose-only inhalation exposure. Male and female Fischer 344 rats (20/sex/group) were exposed 6 h/day, 5 days/week for 3 months to vapor concentrations of 0, 35, 122, 488, and 898 ppm D4. Also, an additional 10 per sex in the control and high-exposure groups were allowed a 4-week recovery period to observe reversibility, persistence, or delayed occurrence of any potential adverse effects. Body weights and food consumption were monitored at least twice weekly over the course of exposures. Approximately 18 hours preceding euthanasia, animals were transferred into metabolism cages for urine collection, and were fasted. At necropsy, rats were anesthetized with pentobarbital and euthanized by exsanguination. Blood was collected for hematological and clinical biochemical analyses. Selected organ weights were measured and a complete set of tissues was taken for histopathological examination. A concentration-dependent increase in absolute and relative liver weight (488 to 898 ppm) and a significant decrease in ovarian weight (898 ppm) were observed in female rats. Exposure to D4 via nose-only inhalation (35 to 898 ppm) produced minor alterations in hematological and serum chemistry parameters that were considered either incidental and of little toxicological significance (hematology) or suggestive of metabolic adaptation/alteration (serum chemistry) in response to exposure-related hepatomegaly. There were no histopathological findings noted in the liver. Histopathological evidence indicated the primary target organs following D4 inhalation exposure to be components of the female reproductive tract. Reversible histopathological changes were observed in the ovary (hypoactivity) and vagina (mucification) of female rats in the high-dose group only (898 ppm). Although an increase in the incidence and severity of both macrophage accumulation, interstitial inflammation, and eosinophil infiltration was observed in the lungs of male and female rats exposed to D4, the toxicological significance is uncertain as other inhalation studies at similar concentrations failed to show these effects. In summary, nose-only inhalation of a high concentration of D4 resulted in reversible histopathological changes in the female rat reproductive tract. Lower concentrations did not elicit these same effects.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009666 Nose A part of the upper respiratory tract. It contains the organ of SMELL. The term includes the external nose, the nasal cavity, and the PARANASAL SINUSES. External Nose,External Noses,Nose, External,Noses,Noses, External
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol

Related Publications

Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
November 1999, Drug and chemical toxicology,
Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
October 2017, Toxicology letters,
Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
October 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology,
Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
May 1998, Toxicological sciences : an official journal of the Society of Toxicology,
Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
January 2023, Toxicology letters,
Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
October 1994, Environmental research,
Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
October 2017, Toxicology letters,
Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
October 2017, Toxicology letters,
Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
February 2000, Drug metabolism and disposition: the biological fate of chemicals,
Leigh Ann Burns-Naas, and Robert G Meeks, and Gary B Kolesar, and Richard W Mast, and Michael R Elwell, and Jerry F Hardisty, and Philippe Thevenaz
June 1979, Toxicology and applied pharmacology,
Copied contents to your clipboard!